| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014310A1 2-[5-AMINO-6-OXO-2-PHENYL-1,6-DIHYDRO-1-PYRIMIDYL]-N-[1-(2-[5-t-BUTYL-1,3,4-OXADIAZOLYL]CARBONYL)-2-(R,S)-METHYLPROPYL]ACETAMIDE HYDROCHLORIDE |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014272A1 (thio)urea derivatives, process for their production and medicines containing the derivatives |
| 02/21/2002 | WO2002014262A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
| 02/21/2002 | WO2002013821A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | WO2002013805A2 Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 02/21/2002 | WO2002013804A2 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 02/21/2002 | WO2002013800A2 Method for the prevention and treatment of retinopathy |
| 02/21/2002 | WO2001090063A3 Prodrug of an ice inhibitor |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001074314A3 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066089A3 Pharmaceutical compositions comprising cannabis |
| 02/21/2002 | WO2001043775A3 Hydroxide-releasing agents as skin permeation enhancers |
| 02/21/2002 | WO2001030323A3 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 02/21/2002 | WO2001026658A3 Topical nasal treatment using desloratadine |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | US20020022654 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 02/21/2002 | US20020022648 Novel 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| 02/21/2002 | US20020022646 Method for systhesizing leflunomide |
| 02/21/2002 | US20020022645 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor |
| 02/21/2002 | US20020022642 As nitric oxide synthase (NOS) inhibitors, used in therapy and prophylaxis of central nervous system disorders, inflammatory disorders, septic shock and other disorders |
| 02/21/2002 | US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | EP1143935A3 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/21/2002 | CA2419158A1 Method for the prevention and treatment of retinopathy |
| 02/21/2002 | CA2419073A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180103A1 Renin inhibitors |
| 02/20/2002 | EP1028707B1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 02/20/2002 | EP0934079B1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336929A Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336920A Telmisartan polymorphs, methods for producing same and their use in prepn. of a medicament |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336819A Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 02/20/2002 | CN1079235C Acetazolamide microemulsion as eyedrops for treating glaucoma and its preparing process |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 02/19/2002 | US6348508 Method for treating dry eye |
| 02/19/2002 | US6348496 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
| 02/19/2002 | US6348459 Sultam and sultone derived oxazolidinones |
| 02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011747A2 Transglutaminase for inhibiting angiogenesis |
| 02/14/2002 | WO2002011739A1 Methods for preventing pressure induced apoptotic neural cell death |
| 02/14/2002 | WO2002011718A1 IgE PRODUCTION INHIBITORS |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011708A2 Methods for inducing apolipoprotein e secretion |
| 02/14/2002 | WO2002011666A2 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 02/14/2002 | WO2002011530A1 Transgenic animal |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001068670A3 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 02/14/2002 | WO2001056598A3 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019433 Methods of treating excessive intraocular pressure |
| 02/14/2002 | US20020019430 Nervous system and psychological disorders |
| 02/14/2002 | US20020019424 1-sulfonyl pyrrolidine derivatives |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020018787 Synergistic mixture of dimethylglycine and mussel extract |
| 02/14/2002 | CA2774959A1 Method of using diketopiperazines and composition containing them |